2024 Syrs investor relations

Syrs investor relations

Author: kvls

August undefined, 2024

WebDec 16, 2024 · What does smart money think about Syros Pharmaceuticals, Inc. (NASDAQ:SYRS)? At Q3's end, a total of 9 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of ... WebHeadquarters. 35 CambridgePark Drive 4th Floor Cambridge, MA 02140 Tel: (617) 744-1340

Contact :: Syros Pharmaceuticals, Inc. (SYRS)

WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ existing management team ... WebApr 12, 2024 · How much institutional selling is happening at Syros Pharmaceuticals? Institutional investors have sold a total of 22,154,450 shares in the last 24 months. This volume of shares sold represents approximately $390.15M in transactions. This page (NASDAQ:SYRS) was last updated on 4/3/2024 by MarketBeat.com Staff. bam margera n

www.cision.com

WebSyros Pharmaceuticals (SYRS) NASDAQ: SYRS. Stock Analysis Analyst Forecasts Technical Analysis Chart Earnings Dividends Financials Insider Trading Crowd Wisdom Hedge … WebSep 15, 2024 · Following the closing of the Merger, the combined company will trade on The Nasdaq Global Select Market under the ticker symbol “SYRS,” and will be led by Syros’ … WebMar 24, 2024 · View Syros Pharmaceuticals, Inc SYRS investment & stock information. Get the latest Syros Pharmaceuticals, Inc SYRS detailed stock quotes, stock data, Real-Time … ar sakiau kad tu man reikalinga pdf

Syros Pharmaceuticals, Inc. (SYRS) - Yahoo Finance

Contacts :: Syros Pharmaceuticals, Inc. (SYRS)

WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment … WebDirector of Corporate Communications & Investor Relations [email protected]. Stern Investor Relations, Inc. Hannah Deresiewicz [email protected]. Transfer Agent. Computershare Trust Company, N.A. Auditor. Ernst & Young LLP 200 Clarendon Street Boston, MA 02116 T: 617-266-2000 arsa indonesia surabayaWebMar 24, 2024 · Get the latest Syros Pharmaceuticals, Inc SYRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... As an investor, you want to buy stocks with the highest probability of ... bam margera missy

"WebOct 18, 2024 · About Syros Pharmaceuticals, Inc. 35 CAMBRIDGEPARK DRIVE 4TH FLOOR, CAMBRIDGE, Massachusetts, 2140, United States +1 617 744-1340 … " - Syrs investor relations

Syrs investor relations

Syros and Tyme Technologies Announce Stockholder Approval of …

WebAug 3, 2024 · Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) Q2 2024 Earnings Call Aug 01, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good... WebOct 14, 2024 · Find the latest SEC Filings data for Syros Pharmaceuticals, Inc. Common Stock (SYRS) at Nasdaq.com. Syros Pharmaceuticals, Inc. Common Stock (SYRS) SEC …

Did you know?

Web83 rows · Get the latest insider transactions for Syros Pharmaceuticals, Inc. (SYRS). Find out the total of insider shares held, purchased and sold. WebOct 3, 2024 · Syros Pharmaceuticals News: Why SYRS Stock Is Shooting 16% Higher Today. By William White, InvestorPlace Writer Dec 18, 2024. Syros Pharmaceuticals (SYRS) news for Wednesday about plans for ...

WebMoved Permanently. The document has moved here. WebFeb 24, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS News Morningstar Rating Rating as of Feb 24, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ...

WebMar 8, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Financial Information Morningstar Rating Rating as of Mar 8, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... WebMar 3, 2024 · Review the current Syros Pharmaceuticals Inc (SYRS:XNAS) dividend yield and history to decide if ATUS stock is the best investment for you. ... Investor Relations Syros Pharmaceuticals Inc SYRS ...

WebFind the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and other vital information to help you with your stock trading and investing.

WebFeb 24, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Sustainability Morningstar Rating Rating as of Nov 22, 2024. Quote Chart Stock Analysis News Price vs Fair Value ... arsa indonesiaWebApr 10, 2024 · Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Lags Revenue Estimates. Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises … arsa kiralamaWebSYRS Dividend History Back to SYRS Overview The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our... arsala bakhtyar beaumontWebSep 15, 2024 · Syros’ Investor Contact: Hannah Deresiewicz Stern Investor Relations, Inc. 212-362-1200 [email protected] Tyme’s Investor Contact … bam margera neWebMar 7, 2024 · Investor Relations Syros Pharmaceuticals Inc SYRS Chart Morningstar Rating Rating as of Mar 7, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... arsakarsaWebMar 2, 2024 · Investor Relations :: Syros Pharmaceuticals, Inc. (SYRS) Syros is redefining the power of small molecules to control gene expression with the aim of providing a … Syros to Participate in Upcoming Investor Conferences in March . Feb 23, 2024. … 2024 BIO CEO & Investor Conference. Feb 6, 2024 • 3:00pm PDT . 35th Annual J.P. … Do you want to load external content supplied by QMod Stock Tools? Yes We respect your privacy. We do not sell, rent, or loan any information to any third … Date Form Description PDF XBRL Pages; 04/06/23: S-3: Registration statement for … © 2024 Syros Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Terms of … CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands. 12 … 2024 Annual Report. 2024 Annual Report. 2024 Annual Report Gerald brings more than 20 years of senior leadership and legal experience in the … ar sakiau kad tu man reikalinga pdf nemokamaiWebSYRS Complete Syros Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. arsala bakhtyar